What are the CDC/ACIP influenza vaccine recommendations?

Updated: Aug 07, 2020
  • Author: Hien H Nguyen, MD, MS; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print

The following are influenza vaccine recommendations by the ACIP:

  • In the Northern Hemisphere, all persons aged 6 months or older should receive influenza vaccine annually, by the end of October, if possible. Influenza vaccination should not be delayed to procure a specific vaccine preparation if an appropriate one is already available.
  • For healthy children aged 2-8 years who have no contraindications or precautions, inactivated influenza vaccine (IIV) is an appropriate option. An age-appropriate formulation of vaccine should be used.
  • Persons with a history of egg allergy who have experienced only hives after exposure to egg should receive influenza vaccine. IIV or trivalent recombinant influenza vaccine (RIV3) should be used. RIV3 may be used for persons aged 18 years or older who have no other contraindications. [9]
  • Regardless of allergy history, all vaccines should be administered in settings in which personnel and equipment for rapid recognition and treatment of anaphylaxis are available.
  • A previous severe allergic reaction to influenza vaccine, regardless of the component suspected of being responsible for the reaction, is a contraindication to future receipt of the vaccine.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!